Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 30-Sep 2021. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4589173018 | Ertugliflozin pidolate | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4589174012 | Ertugliflozin pidolate (substance) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Ertugliflozin pidolate | Is a | Sodium glucose cotransporter subtype 2 inhibitor | true | Inferred relationship | Some | ||
| Ertugliflozin pidolate | Has disposition (attribute) | Sodium glucose cotransporter subtype 2 inhibitor (disposition) | true | Inferred relationship | Some | ||
| Ertugliflozin pidolate | Is modification of (attribute) | Ertugliflozin | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely ertugliflozin (as ertugliflozin pidolate) 15 milligram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | True | Ertugliflozin pidolate | Inferred relationship | Some | 1 |
| Ertugliflozin (as ertugliflozin pidolate) 5 mg oral tablet | Has precise active ingredient | True | Ertugliflozin pidolate | Inferred relationship | Some | 1 |
Reference Sets
Belgian subset for AllergyIntolerance, causative agent, drug
FHIR